🚀 VC round data is live in beta, check it out!
Clicks Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Clicks Group and similar public comparables like Yifeng Pharmacy, Sugi Holdings, Jointown Pharmaceutical, CR Pharmaceutical and more.
Clicks Group Overview
About Clicks Group
Clicks Group Ltd operates prominently in health, beauty, and wellness retail across southern Africa. The company predominantly operates a retail pharmacy chain in South Africa, with a limited number of operations in bordering countries. The company has a portfolio of retail franchise brands including The Body Shop, M-Kem, and Sorbet among others. The company's business segments include Retail and Distribution. The company generates revenue from in-store and online sales of health, beauty, and wellness items, plus wholesale pharmaceutical distribution. Geographically, the maximum revenue is generated from South Africa.
Founded
1968
HQ
Employees
20.1K
Website
Sectors
Financials (LTM)
EV
$4B
Clicks Group Financials
Clicks Group reported last 12-month revenue of $3B and EBITDA of $407M.
In the same LTM period, Clicks Group generated $703M in gross profit, $407M in EBITDA, and $200M in net income.
Revenue (LTM)
Clicks Group P&L
In the most recent fiscal year, Clicks Group reported revenue of $3B and EBITDA of $401M.
Clicks Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | $703M | XXX | $683M | XXX | XXX | XXX |
| Gross Margin | 24% | XXX | 24% | XXX | XXX | XXX |
| EBITDA | $407M | XXX | $401M | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| EBIT Margin | 10% | XXX | 10% | XXX | XXX | XXX |
| Net Profit | $200M | XXX | $194M | XXX | XXX | XXX |
| Net Margin | 7% | XXX | 7% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Clicks Group Stock Performance
Clicks Group has current market cap of $4B, and enterprise value of $4B.
Market Cap Evolution
Clicks Group's stock price is $18.95.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4B | $4B | 0.0% | XXX | XXX | XXX | $0.83 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialClicks Group Valuation Multiples
Clicks Group trades at 1.5x EV/Revenue multiple, and 11.0x EV/EBITDA.
EV / Revenue (LTM)
Clicks Group Financial Valuation Multiples
As of March 19, 2026, Clicks Group has market cap of $4B and EV of $4B.
Equity research analysts estimate Clicks Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Clicks Group has a P/E ratio of 22.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV/Revenue | 1.5x | XXX | 1.6x | XXX | XXX | XXX |
| EV/EBITDA | 11.0x | XXX | 11.2x | XXX | XXX | XXX |
| EV/EBIT | 15.6x | XXX | 16.0x | XXX | XXX | XXX |
| EV/Gross Profit | 6.4x | XXX | 6.6x | XXX | XXX | XXX |
| P/E | 22.2x | XXX | 22.9x | XXX | XXX | XXX |
| EV/FCF | 24.2x | XXX | 23.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Clicks Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Clicks Group Margins & Growth Rates
Clicks Group's revenue in the last 12 month grew by 10%.
Clicks Group's revenue per employee in the last FY averaged $0.1M.
Clicks Group's rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Clicks Group's rule of X is 38% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Clicks Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | 10% | XXX | 6% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 23% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 38% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 14% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Clicks Group Public Comps
See public comps and valuation multiples for other Pharmacies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Yifeng Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| Sugi Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Jointown Pharmaceutical | XXX | XXX | XXX | XXX | XXX | XXX |
| CR Pharmaceutical | XXX | XXX | XXX | XXX | XXX | XXX |
| COSMOS Pharmaceutical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Clicks Group M&A Activity
Clicks Group acquired XXX companies to date.
Last acquisition by Clicks Group was on XXXXXXXX, XXXXX. Clicks Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Clicks Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialClicks Group Investment Activity
Clicks Group invested in XXX companies to date.
Clicks Group made its latest investment on XXXXXXXX, XXXXX. Clicks Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Clicks Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Clicks Group
| When was Clicks Group founded? | Clicks Group was founded in 1968. |
| Where is Clicks Group headquartered? | Clicks Group is headquartered in South Africa. |
| How many employees does Clicks Group have? | As of today, Clicks Group has over 20K employees. |
| Who is the CEO of Clicks Group? | Clicks Group's CEO is Bertina Engelbrecht. |
| Is Clicks Group publicly listed? | Yes, Clicks Group is a public company listed on Johannesburg Stock Exchange. |
| What is the stock symbol of Clicks Group? | Clicks Group trades under CLS ticker. |
| When did Clicks Group go public? | Clicks Group went public in 1996. |
| Who are competitors of Clicks Group? | Clicks Group main competitors are Yifeng Pharmacy, Sugi Holdings, Jointown Pharmaceutical, CR Pharmaceutical. |
| What is the current market cap of Clicks Group? | Clicks Group's current market cap is $4B. |
| What is the current revenue of Clicks Group? | Clicks Group's last 12 months revenue is $3B. |
| What is the current revenue growth of Clicks Group? | Clicks Group revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of Clicks Group? | Current revenue multiple of Clicks Group is 1.5x. |
| Is Clicks Group profitable? | Yes, Clicks Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Clicks Group? | Clicks Group's last 12 months EBITDA is $407M. |
| What is Clicks Group's EBITDA margin? | Clicks Group's last 12 months EBITDA margin is 14%. |
| What is the current EV/EBITDA multiple of Clicks Group? | Current EBITDA multiple of Clicks Group is 11.0x. |
| What is the current FCF of Clicks Group? | Clicks Group's last 12 months FCF is $185M. |
| What is Clicks Group's FCF margin? | Clicks Group's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of Clicks Group? | Current FCF multiple of Clicks Group is 24.2x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.